These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7669735)
1. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Kuroki T; Fujiwara Y; Tsuchiya E; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y Genes Chromosomes Cancer; 1995 Jul; 13(3):163-7. PubMed ID: 7669735 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882 [TBL] [Abstract][Full Text] [Related]
3. Allelotype analysis of hepatocellular carcinoma. Piao Z; Park C; Park JH; Kim H Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686 [TBL] [Abstract][Full Text] [Related]
4. Genetic changes and histopathological grades in human hepatocellular carcinomas. Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376 [TBL] [Abstract][Full Text] [Related]
6. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma. Tamura S; Nakamori S; Kuroki T; Sasaki Y; Furukawa H; Ishikawa O; Imaoka S; Nakamura Y J Hepatol; 1997 Oct; 27(4):669-76. PubMed ID: 9365043 [TBL] [Abstract][Full Text] [Related]
7. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Emi M; Fujiwara Y; Ohata H; Tsuda H; Hirohashi S; Koike M; Miyaki M; Monden M; Nakamura Y Genes Chromosomes Cancer; 1993 Jul; 7(3):152-7. PubMed ID: 7687868 [TBL] [Abstract][Full Text] [Related]
8. Chromosomal instability and human hepatocarcinogenesis. Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902 [TBL] [Abstract][Full Text] [Related]
9. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive allelotyping of human hepatocellular carcinoma. Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss. Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Wong CM; Lee JM; Lau TC; Fan ST; Ng IO Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China. Zhang SH; Cong WM; Xian ZH; Wu MC World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma. Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Kuroki T; Fujiwara Y; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y Br J Cancer; 1995 Aug; 72(2):383-5. PubMed ID: 7640222 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma. Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122 [TBL] [Abstract][Full Text] [Related]
18. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation. Chan KL; Lee JM; Guan XY; Fan ST; Ng IO Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350 [TBL] [Abstract][Full Text] [Related]